Skip to main
EHAB
EHAB logo

Enhabit Inc (EHAB) Stock Forecast & Price Target

Enhabit Inc (EHAB) Analyst Ratings

Based on 10 analyst ratings
Hold
Strong Buy 20%
Buy 0%
Hold 70%
Sell 10%
Strong Sell 0%

Bulls say

Enhabit Inc is actively advancing its payor innovation strategy, with a significant 45% of non-Medicare visits under contracts that provide improved rates, reflecting a slight increase of 2 percentage points quarter-over-quarter. The hospice segment is expected to achieve a core growth rate of 2.5% in 2024, bolstered by a successful new case management model that has enhanced hospice average daily census by 7% and improved revenue per day by 3.9% due to updated Medicare rates. Additionally, Enhabit has seen a noteworthy improvement in adjusted EBITDA margins, which increased by 1,100 basis points to 22.9%, demonstrating operational efficiency despite a minor year-over-year decline in revenue per episode.

Bears say

Enhabit Inc. has demonstrated operational stability; however, its financial outlook remains negative, primarily due to a significant EBITDA decline of 13% year-over-year in the home health segment. The company faces numerous downside risks, including potential regulatory changes from CMS, an inability to achieve internal growth targets, and elevated leverage that could jeopardize covenant compliance and hinder growth flexibility. Additionally, a projected $15 million reduction in Medicare revenue from a 2.6% cut and an ongoing challenging reimbursement environment contribute to a forecast of flat earnings over the multi-year horizon, raising concerns regarding long-term financial viability.

Enhabit Inc (EHAB) has been analyzed by 10 analysts, with a consensus rating of Hold. 20% of analysts recommend a Strong Buy, 0% recommend Buy, 70% suggest Holding, 10% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Enhabit Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Enhabit Inc (EHAB) Forecast

Analysts have given Enhabit Inc (EHAB) a Hold based on their latest research and market trends.

According to 10 analysts, Enhabit Inc (EHAB) has a Hold consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $12.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $12.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Enhabit Inc (EHAB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.